Interestingly, data from the TCGA (GDC DataPortal) repository revealed a significant association between low ANKRD2 expression and improved overall survival in head and neck squamous cell carcinoma (HNSC), lung adenocarcinoma (LUAD), and uveal melanoma (UVM) (Supplementary Figure S2). This evidence concerns the gene ANKRD2 and head and neck squamous cell carcinoma.